Utah

Utah runs one of the country’s most restrictive intoxicating cannabinoid frameworks and is effectively closed to hemp beverage brands. The regulatory stack is layered: Utah Code Title 4, Chapter 41 governs hemp; Chapter 41a governs cannabinoid products; HB 227 (2023) added the operative product restrictions; HB 54 (2025) tightened them further; and the UDAF Manufactured Food Rule § 5.4 delivers the categorical prohibition that closes the beverage segment. HB 227 (2023) established three defining rules: (1) all products containing any THC — even trace amounts — restricted to adults 21 years and older with ID verification; (2) products may not exceed 5mg THC per serving or 150mg per package; and (3) all cannabinoid products sold in Utah must be registered with the Utah Department of Agriculture and Food (UDAF) before sale. HB 227 also explicitly banned synthesized or chemically converted cannabinoids including delta-8 THC, delta-10 THC, and HHC, and required specific health warning statements on all inhalable cannabinoid product labeling. HB 54 (Cannabinoid Amendments, 2025) was signed by Gov. Spencer Cox on March 24, 2025 and took effect on May 7, 2025. HB 54 expanded the synthetic cannabinoid ban to explicitly cover THCP, THCB, and any THC analogs or isomers with intoxicating effects. It requires hemp products to contain less than 0.3% combined THC and THC analogs by dry weight at the plant stage. Retailers face civil penalties up to $5,000 per violation under Utah Code § 4-41a-1101, and repeat offenders can be referred for criminal prosecution under Utah Code § 58-37. The most decisive barrier for hemp beverage brands is UDAF Manufactured Food Rule § 5.4, which prohibits food processors from adding THC to foods or from allowing storage, handling, and production of THC-containing products on food processing equipment. That rule, in combination with HB 227’s registration requirement, means CBD gummies and all CBD-infused food products including beverages cannot be legally registered or sold in Utah. Legal oral formats for hemp cannabinoid products in Utah are limited to tinctures, capsules, softgels, and tablets. Since HB 54 took effect on May 7, 2025, UDAF and local law enforcement have run joint sweeps targeting delta-8, delta-10, HHC, THC-O, and other synthetic cannabinoids at convenience stores, smoke shops, and gas stations. Stop-sale orders and civil penalties have followed. HB 385 (2022) transferred hemp cultivation licensing from UDAF to the USDA Domestic Hemp Production Program, so Utah hemp producers now apply directly through USDA’s Hemp eManagement Platform (HeMP). As of August 2025, there were approximately 46 USDA-licensed hemp growers operating in Utah. UDAF continues to regulate processors, retail permit holders, and cannabinoid product registrations. Utah’s medical cannabis program is uniquely structured. Proposition 2, voter-approved in November 2018 with 53% support, was substantially rewritten by the legislature via HB 3001 (Utah Medical Cannabis Act) during a special session before the initiative took effect. HB 3001 eliminated home cultivation, reduced qualifying conditions, and replaced traditional dispensaries with a pharmacist-dispensed model — the only such model in the country. The program has grown to over 100,000 registered patients as of 2025-2026, served by 17 licensed medical cannabis pharmacies statewide (HB 54 added two new rural licenses in 2025-2026). DHHS administers the program through the Center for Medical Cannabis. Qualifying conditions include HIV/AIDS, Alzheimer’s, ALS, cancer, Crohn’s, epilepsy, MS, PTSD, chronic pain, autism, and terminal illness. Patient possession limits: 113 grams unprocessed cannabis flower, 20 grams total composite THC in other dosage forms. HB 357 (2025) simplified physician eligibility to recommend medical cannabis, dropped some registration fees, and added pregnancy warning label requirements. For the federal cliff on November 12, 2026, Utah is a state where Section 781 largely does not change the operative regulatory picture — Utah is already closed to hemp beverages, and its framework already excludes synthetic cannabinoids, applies a total-THC-and-analogs standard broader than Section 781’s federal definition, and channels intoxicating THC access to the medical pharmacy program. Section 781’s 0.4mg total-THC per-container federal ceiling is tighter than Utah’s 5mg per-serving cap for the tinctures/capsules/softgels/tablets lane that remains lawful, but that dimension is a marginal effect compared to Utah’s overall closure to the beverage segment. Practical disruption from Section 781 for Utah operators focused on beverage is nil.